Vanguard Group Inc. Buys 681,278 Shares of Acadia Healthcare Company, Inc. $ACHC

Vanguard Group Inc. grew its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 7.8% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 9,417,045 shares of the company’s stock after acquiring an additional 681,278 shares during the quarter. Vanguard Group Inc. owned about 0.10% of Acadia Healthcare worth $233,166,000 as of its most recent SEC filing.

Several other large investors have also made changes to their positions in ACHC. Allworth Financial LP raised its position in Acadia Healthcare by 676.4% during the 2nd quarter. Allworth Financial LP now owns 1,351 shares of the company’s stock worth $31,000 after purchasing an additional 1,177 shares during the last quarter. EverSource Wealth Advisors LLC raised its position in shares of Acadia Healthcare by 54.8% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock worth $32,000 after acquiring an additional 497 shares in the last quarter. Hantz Financial Services Inc. grew its position in shares of Acadia Healthcare by 501.9% during the 3rd quarter. Hantz Financial Services Inc. now owns 2,185 shares of the company’s stock worth $54,000 after buying an additional 1,822 shares during the period. CWM LLC boosted its position in shares of Acadia Healthcare by 105.1% during the 2nd quarter. CWM LLC now owns 2,633 shares of the company’s stock worth $60,000 after purchasing an additional 1,349 shares in the last quarter. Finally, Quent Capital LLC acquired a new stake in Acadia Healthcare in the 3rd quarter valued at $71,000.

Trending Headlines about Acadia Healthcare

Here are the key news stories impacting Acadia Healthcare this week:

• Positive Sentiment: Q4 revenue topped estimates and EPS beat consensus, driving a strong intraday jump; management provided FY2026 and Q1 2026 guidance that gave investors a clearer outlook. Acadia Healthcare’s (NASDAQ:ACHC) Q4 CY2025 Sales Top Estimates, Stock Jumps 10.8%
• Positive Sentiment: The company posted its Q4 earnings presentation and materials, helping investors parse revenue mix, margin drivers and the path to management’s FY26 targets. Acadia Healthcare Company, Inc. 2025 Q4 – Results – Earnings Call Presentation
• Positive Sentiment: Multiple brokerages raised price targets and maintain buy/outperform stances—RBC to $28 (outperform), UBS to $27 (buy) and TD Cowen to $24 (buy)—which increases buy-side conviction and likely supported the rally. Benzinga: Analyst Price-Target Updates
• Positive Sentiment: Analysts and commentary highlighted improving execution and embedded EBITDA opportunities under returning management, reinforcing the view that operational fixes could restore profitability. TipRanks: Buy Rating on Improving Execution
• Neutral Sentiment: Aggregated analyst coverage: a Benzinga deep-dive summarizes 17 analyst ratings and consensus perspectives — useful for context on how Street expectations are shifting but not a single catalyst. Acadia Healthcare Co Stock: A Deep Dive Into Analyst Perspectives (17 Ratings)
• Negative Sentiment: Short interest remains very large (~32.45M shares as of mid‑Feb, ~35.9% of float) with a ~7.3 days-to-cover ratio — this high short position increases the risk of volatile trading, squeezes, or pressure if execution disappoints. (short-interest reports summarized in filings and market data)

Acadia Healthcare Stock Performance

Shares of ACHC stock opened at $23.44 on Monday. The company has a quick ratio of 1.44, a current ratio of 1.55 and a debt-to-equity ratio of 1.27. The company has a 50 day moving average price of $14.82 and a 200-day moving average price of $18.55. Acadia Healthcare Company, Inc. has a 52 week low of $11.43 and a 52 week high of $33.58. The firm has a market capitalization of $2.16 billion, a PE ratio of -1.92, a P/E/G ratio of 8.01 and a beta of 0.89.

Acadia Healthcare (NASDAQ:ACHC) last released its quarterly earnings results on Wednesday, February 25th. The company reported $0.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.03 by $0.04. The firm had revenue of $821.46 million for the quarter, compared to the consensus estimate of $800.10 million. Acadia Healthcare had a positive return on equity of 6.53% and a negative net margin of 33.29%.The company’s revenue for the quarter was up 6.1% on a year-over-year basis. During the same period last year, the business posted $0.64 EPS. Acadia Healthcare has set its FY 2026 guidance at 1.300-1.550 EPS and its Q1 2026 guidance at 0.250-0.300 EPS. As a group, equities research analysts expect that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current year.

Analyst Ratings Changes

ACHC has been the subject of a number of recent research reports. Raymond James Financial reissued an “outperform” rating and issued a $25.00 target price on shares of Acadia Healthcare in a research report on Thursday. Royal Bank Of Canada boosted their target price on shares of Acadia Healthcare from $17.00 to $28.00 and gave the company an “outperform” rating in a report on Thursday. Leerink Partners increased their price objective on Acadia Healthcare from $14.00 to $22.00 and gave the stock a “market perform” rating in a report on Thursday. Guggenheim cut their price objective on shares of Acadia Healthcare from $27.00 to $22.00 and set a “buy” rating for the company in a research report on Monday, February 23rd. Finally, Bank of America cut shares of Acadia Healthcare from a “neutral” rating to an “underperform” rating and lowered their target price for the stock from $21.50 to $13.00 in a research note on Wednesday, December 3rd. Seven investment analysts have rated the stock with a Buy rating, six have given a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $20.69.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.